NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Thursday that its fiscal 2018 first quarter revenues rose 5 percent year over year, thanks largely to a 10 percent increase in revenues from its clinical labs business.

For the three months ended Oct. 31, the molecular diagnostics company reported total revenues of $27.7 million, up from $26.3 million in Q1 2017.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.